TABLE 3.
Study | CAR T | Median Progression-free Survival, months | Median Follow-Up, months |
---|---|---|---|
Locke et al. (2019) | axi-cel | 5.9 (3.3–15.0) | 27.1 |
Abramson et al. (2020) | liso-cel | 6.8 (3.3–12.7) | 23.9 |
Ying et al. (2021) | relma-cel | 7.0 (4.8-NR) | 17.9 |
Nastoupil et al. (2020) | axi-cel | 8.3 (6.0–15.1) | 12.9 |
Iacoboni et al. (2021) | tisa-cel | 3.0 (2.6–4.7) | 14.1 |
Grana et al. (2021) | axi-cel | 5.8 | 6.0 |
CAR T: chimeric antigen receptor T cells; NR: not reached.